HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Deborah J Marshall Selected Research

intetumumab

4/2014Metastatic signature in lung cancer is associated with sensitivity to anti-integrin α(V) monoclonal antibody intetumumab.
3/2013Dual inhibition of αV integrins and Src kinase activity as a combination therapy strategy for colorectal cancer.
10/2012Targeting αV-integrins decreased metastasis and increased survival in a nude rat breast cancer brain metastasis model.
8/2011Expression of αV-integrins in uterine serous papillary carcinomas; implications for targeted therapy with intetumumab (CNTO 95), a fully human antagonist anti-αV-integrin antibody.
1/2011Dynamic magnetic resonance imaging assessment of vascular targeting agent effects in rat intracerebral tumor models.
10/2010Anti-alphav integrin monoclonal antibody intetumumab enhances the efficacy of radiation therapy and reduces metastasis of human cancer xenografts in nude rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Deborah J Marshall Research Topics

Disease

9Neoplasms (Cancer)
08/2014 - 11/2005
3Neoplasm Metastasis (Metastasis)
04/2014 - 10/2010
2Breast Neoplasms (Breast Cancer)
10/2012 - 02/2006
2Prostatic Neoplasms (Prostate Cancer)
02/2006 - 11/2005
1Lung Neoplasms (Lung Cancer)
04/2014
1Colorectal Neoplasms (Colorectal Cancer)
03/2013
1Colonic Neoplasms (Colon Cancer)
03/2013
1Papillary Carcinoma
08/2011
1Endometrial Neoplasms (Endometrial Cancer)
08/2011
1Brain Neoplasms (Brain Tumor)
01/2011
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2010
1Head and Neck Neoplasms (Head and Neck Cancer)
10/2010

Drug/Important Bio-Agent (IBA)

7IntegrinsIBA
08/2014 - 10/2010
6intetumumabIBA
04/2014 - 10/2010
3Monoclonal AntibodiesIBA
04/2014 - 10/2010
3Prostate-Specific Antigen (Semenogelase)IBA
02/2006 - 11/2005
2DNA VaccinesIBA
01/2006 - 11/2005
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
08/2014
1AntibodiesIBA
08/2014
1CytokinesIBA
08/2014
1Trastuzumab (Herceptin)FDA Link
08/2014
1MicroRNAs (MicroRNA)IBA
04/2014
1src-Family KinasesIBA
03/2013
1Dasatinib (BMS 354825)FDA Link
03/2013
1Bevacizumab (Avastin)FDA Link
01/2011
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2011
1Ferrosoferric Oxide (Magnetite)FDA Link
01/2011
1Integrin alphaVIBA
10/2010
1Erythropoietin Receptors (Erythropoietin Receptor)IBA
02/2006
1Tumor Biomarkers (Tumor Markers)IBA
02/2006
1Paclitaxel (Taxol)FDA LinkGeneric
02/2006
1ErythropoietinFDA Link
02/2006
1epoetin betaIBA
02/2006
1Interleukin-18 (Interleukin 18)IBA
01/2006
1VaccinesIBA
01/2006
1A-Form DNA (A-DNA)IBA
01/2006
1Biomarkers (Surrogate Marker)IBA
11/2005
1AutoantigensIBA
11/2005
1EpitopesIBA
11/2005

Therapy/Procedure

4Therapeutics
04/2014 - 02/2006
2Aftercare (After-Treatment)
01/2011 - 10/2010
1Drug Therapy (Chemotherapy)
08/2011
1Microbubbles
10/2010
1Radiotherapy
10/2010